Pharmaron Beijing Co., Ltd. (FRA:17Q1)

Pharmaron Beijing Statistics

Total Valuation

FRA:17Q1 has a market cap or net worth of EUR 6.04 billion. The enterprise value is 6.61 billion.

Market Cap	6.04B
Enterprise Value	6.61B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	Jul 4, 2025

Share Statistics

Current Share Class	294.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.45%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	7.82%
Owned by Institutions (%)	23.00%
Float	1.16B

Valuation Ratios

The trailing PE ratio is 33.35 and the forward PE ratio is 23.56.

PE Ratio	33.35
Forward PE	23.56
PS Ratio	3.72
PB Ratio	3.32
P/TBV Ratio	4.68
P/FCF Ratio	63.03
P/OCF Ratio	15.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.72, with an EV/FCF ratio of 68.97.

EV / Earnings	36.49
EV / Sales	4.01
EV / EBITDA	17.72
EV / EBIT	27.99
EV / FCF	68.97

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.42.

Current Ratio	1.50
Quick Ratio	1.03
Debt / Equity	0.42
Debt / EBITDA	2.08
Debt / FCF	7.98
Interest Coverage	8.51

Financial Efficiency

Return on equity (ROE) is 9.66% and return on invested capital (ROIC) is 5.85%.

Return on Equity (ROE)	9.66%
Return on Assets (ROA)	4.91%
Return on Invested Capital (ROIC)	5.85%
Return on Capital Employed (ROCE)	9.42%
Revenue Per Employee	75,877
Profits Per Employee	8,473
Employee Count	21,370
Asset Turnover	0.55
Inventory Turnover	6.86

Taxes

In the past 12 months, FRA:17Q1 has paid 46.39 million in taxes.

Income Tax	46.39M
Effective Tax Rate	21.55%

Stock Price Statistics

The stock price has increased by +51.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+51.25%
50-Day Moving Average	2.72
200-Day Moving Average	2.15
Relative Strength Index (RSI)	42.08
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:17Q1 had revenue of EUR 1.62 billion and earned 181.07 million in profits. Earnings per share was 0.10.

Revenue	1.62B
Gross Profit	556.66M
Operating Income	232.33M
Pretax Income	215.29M
Net Income	181.07M
EBITDA	346.65M
EBIT	232.33M
Earnings Per Share (EPS)	0.10

Balance Sheet

The company has 272.92 million in cash and 764.84 million in debt, giving a net cash position of -491.92 million.

Cash & Cash Equivalents	272.92M
Total Debt	764.84M
Net Cash	-491.92M
Net Cash Per Share	n/a
Equity (Book Value)	1.82B
Book Value Per Share	0.99
Working Capital	313.58M

Cash Flow

In the last 12 months, operating cash flow was 388.16 million and capital expenditures -292.36 million, giving a free cash flow of 95.80 million.

Operating Cash Flow	388.16M
Capital Expenditures	-292.36M
Free Cash Flow	95.80M
FCF Per Share	n/a

Margins

Gross margin is 34.33%, with operating and profit margins of 14.33% and 11.17%.

Gross Margin	34.33%
Operating Margin	14.33%
Pretax Margin	13.28%
Profit Margin	11.17%
EBITDA Margin	21.38%
EBIT Margin	14.33%
FCF Margin	5.91%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.98%.

Dividend Per Share	0.02
Dividend Yield	0.98%
Dividend Growth (YoY)	-10.16%
Years of Dividend Growth	n/a
Payout Ratio	34.92%
Buyback Yield	0.45%
Shareholder Yield	1.42%
Earnings Yield	3.00%
FCF Yield	1.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 18, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 18, 2023
Split Type	Forward
Split Ratio	1.5

Scores

FRA:17Q1 has an Altman Z-Score of 3.87 and a Piotroski F-Score of 7.

Altman Z-Score	3.87
Piotroski F-Score	7